摘要
目的比较文拉法辛和帕罗西汀治疗首发抑郁症的效果。方法随机选取2014年1月—2015年5月期间医院收治的首发抑郁症患者80例作为研究对象,根据治疗方式的不同将患者分为观察组和对照组,每组40例。对照组接受帕罗西汀治疗,观察组给予文拉法辛治疗。结果观察组治疗后的HAMA评分、HAMD评分分别为(3.5±2.3)分、(6.4±3.3)分,均优于对照组(P<0.05)。结论文拉法辛治疗首发抑郁症能显著改善患者易于、焦虑症状,且不良反应较少,值得进一步推广。
Objective To compare the effect of venlafaxine and paroxetine in treatment of first-episode depression. Methods 80 cases of patients with first-episode depression admitted and treated in the hospital from January 2014 to May 2015 were selected as the research object and divided into two groups with 40 cases in each according to the different treatment methods, the control group were treated with paroxetine, the observation group were treated with venlafaxine. Results The HAMA score and HAMD score after treatment were respectively（3.5±2.3）points and（6.4±3.3）points in the observation group, which were better than those in the control group,（P〈 0.05）. Conclusion Venlafaxine in treatment of first-episode depression can obviously improve the patient＇s symptoms such as depression and anxiety with fewer adverse reactions,which is worth further promotion.
出处
《中外医疗》
2016年第6期98-99,共2页
China & Foreign Medical Treatment
关键词
首发抑郁症
帕罗西汀
文拉法辛
对比
First-episode depression
Paroxetine
Venlafaxine
Comparison
